Might procalcitonin help predict imported falciparum malaria in children?

Alexandra Tielli1, Rachidou Ouorou2, Lauren Pull1

  • 1Service D'accueil des Urgences Pédiatriques, Hôpital Robert Debré, Assistance Publique-Hôpitaux de Paris (AP-HP), 75019, Paris, France.

Insights

Procalcitonin (PCT) levels can help assess malaria severity in children. A low PCT level may help rule out malaria in travelers, while higher levels indicate severe disease.

Area of Science:

  • Biochemistry
  • Infectious Diseases
  • Pediatrics

Background:

  • Procalcitonin (PCT) is a potential biomarker for malaria severity in adults.
  • Its utility in pediatric malaria cases remains under investigation.
  • A threshold of 10 ng/ml has been suggested for severe falciparum malaria in adults.

Purpose of the Study:

  • To evaluate the effectiveness of PCT as a marker for malaria severity in children.
  • To compare PCT levels between children with uncomplicated malaria, severe malaria, and healthy controls.
  • To establish a PCT threshold for differentiating malaria severity in pediatric patients.

Main Methods:

  • Retrospective case-control study design.
  • Comparison of initial PCT levels in children with uncomplicated malaria versus controls.
  • Comparison of PCT levels between children with uncomplicated and severe malaria.

Main Results:

  • Malaria cases exhibited significantly higher PCT levels than controls.
  • Severe malaria cases showed significantly higher PCT levels than uncomplicated cases.
  • A PCT threshold of 0.65 ng/ml demonstrated high negative predictive value (98.8%) for malaria.
  • Pooled analysis suggested a 6.17 ng/ml threshold for distinguishing severe from uncomplicated malaria.

Conclusions:

  • Procalcitonin may serve as a valuable tool in diagnosing malaria in children.
  • PCT can aid in predicting disease severity, potentially guiding treatment decisions.
  • It may assist in ruling out malaria and assessing severity in pediatric patients and travelers.
Abstract